SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors react to the company's WWDC keynote, which unveiled new 'Apple Intelligence' features and partnerships with Google and Nvidia. While some community members are excited about the AI integration and ecosystem expansion, many others are selling into the news, citing concerns over delayed rollouts in key markets and a perceived lack of original innovation.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is seeing heightened trading volume and sentiment following reports of a significant new AI chip partnership with ByteDance, which investors view as a key strategic move to diversify its revenue beyond mobile handsets. The community is actively debating whether this deal validates the company's shift toward data center and edge AI infrastructure or if the stock remains susceptible to volatility and sector-wide sentiment shifts.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is seeing heightened community discussion as traders scrutinize Phase 3 trial timelines and potential acquisition catalysts, while closely comparing the tolerability profile of VK2735 against competitors like Eli Lilly's Reta. Investors are specifically focused on the upcoming maintenance trial data as a critical inflection point that could solidify the drug's best-in-class potential and drive a valuation re-rating.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following the announcement of a massive 15-year AI data center lease with a hyperscaler, a move that community members are highlighting as a major validator of the company's long-term revenue visibility and growth strategy. Investors are actively discussing the stock's significant contracted backlog and the potential for a long-term re-rating, with many viewing recent volatility as a base-building opportunity ahead of further momentum.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is currently navigating intense market headwinds, including clinical setbacks with its next-generation drug candidate and increasing competition from rival obesity treatments. Despite these challenges, the community is focused on the strong prescription volume of its oral semaglutide and potential opportunities for long-term growth as the company works to solidify its position in the evolving weight-management sector.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as community members weigh the potential antitrust approval of its major acquisition of Warner Bros. Discovery against ongoing regulatory scrutiny. Discussions are largely focused on the potential impact of this consolidation on the broader media landscape, future corporate strategy, and the stock's recent price volatility.

Green Thumb Industries, Inc. engages in the manufacture and distribution of branded cannabis products. Its brands include RYTHM, Dogwalkers, Beboe, Good Green, Doctor Solomon’s, and &Shine. It operates through the Retail and Consumer Packaged Goods segments. The Retail segment focuses on retailing cannabis to patients and consumers. The Consumer Packaged Goods segment refers to the cultivation, production, and sale of cannabis products to retail stores. The company was founded by Benjamin Kovler and Max Cohen on February 18, 2002 and is headquartered in Chicago, IL.

Green Thumb Industries Inc - Ordinary Shares (Sub Voting)

Green Thumb Industries

Green Thumb Industries is trending as investors monitor ongoing federal rescheduling developments and evaluate the impact of new regulations on the broader cannabis market. The community remains focused on the company's strong balance sheet and cash flow, with active debate regarding its potential path toward major exchange uplisting.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to anticipation surrounding the release of pivotal clinical data for its in vivo CAR-T therapy, fueling investor speculation regarding a potential buyout by major pharmaceutical partners. The community is actively discussing the company's valuation gap, its growing leadership in the cell therapy space, and the strategic positioning of its pipeline ahead of upcoming medical congress presentations.

NextNav, Inc. engages in development of positioning, navigation, and timing solutions. Its products include NextNav Pinnacle, NextNav 3D, and NextNav TerraPoiNT. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in Reston, VA.

NextNav Inc

NextNav is seeing heightened volatility as investors debate the timing of a long-anticipated FCC Notice of Proposed Rulemaking (NPRM) for its 900 MHz spectrum. While the community is currently reacting to legislative noise and agenda delays, the core conversation remains anchored in the company's valuation as a scarce PNT and spectrum asset that could attract significant interest from major telecommunications and satellite bidders.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve is trending as investors rally around its upcoming NYSE uplisting, viewing the move as a major institutional catalyst and a significant milestone for the US cannabis sector. The community is actively discussing the company's strong market position in Florida and the potential for increased institutional capital as it prepares to transition away from the OTC market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MoonLake Immunotherapeutics CFO Trims His Stake. Should Investors Be Concerned?

Key PointsBodenstedt sold 13,653 shares for a transaction value of ~$273,000 at around $20.02 per share on May 11, 2026...

MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on FDA Progress

MoonLake Immunotherapeutics (MLTX) Price Target Raised to $45 At H.C. Wainwright on FDA Progress...

Nasdaq, S&P 500 Futures Dip As Trump-Iran Tensions Lift Crude Oil Prices: Why MU, MRAM, MLTX, DRTS, ASTS Are In Focus

Equity

Data from Stocktwits shows that retail traders’ sentiment has remained ‘bullish’ on SPY and QQQ, following last week’s resilience in tech and AI-linked names. 


Dow, S&P 500, Nasdaq Futures Slip As Trump Calls Iran’s Peace Proposal ‘Totally Unacceptable’ — MU, SNDK, MRAM, MLTX Stocks In Focus

Iran’s “multipage” response reportedly included opening the Hormuz Strait prior to making nuclear concessions, while also agreeing to export some of its highly enriched uranium to a third country.

MLTX Stock Soars Overnight After FDA Backs Skin Drug Filing — Analyst Sees Over 300% Upside On ‘Best-In-Class’ Label

The company plans to submit its biologics license application (BLA) by September.


MoonLake Immunotherapeutics (MLTX) to Release Earnings on Monday

MoonLake Immunotherapeutics (NASDAQ:MLTX) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-moonlake-immunotherapeutics-stock...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Rating of "Hold" from Brokerages

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) has been given an average rating of "Hold" by the sixteen brokerages that are presently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, four have issued a hold r...

Short Interest in MoonLake Immunotherapeutics (NASDAQ:MLTX) Decreases By 14.2%

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) saw a large decrease in short interest in April. As of April 15th, there was short interest totaling 6,654,522 shares, a decrease of 14.2% from the March 31st total of 7,757,169 shares. Based on an average daily trading volume, of...

The CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?

Key PointsCEO Jorge Santos da Silva sold 150,000 shares for a transaction value of approximately ~$2.75 million, based on a weighted average sale price of $18.35 per share...

MoonLake Immunotherapeutics (NASDAQ:MLTX) CEO Sells $945,644.79 in Stock

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) CEO Da Silva Jorge Santos sold 51,873 shares of the company's stock in a transaction dated Monday, April 13th. The shares were sold at an...

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

Bullish Sentiment

MoonLake Immunotherapeutics

Investors are bracing for a potential buyout war among Big Pharma giants triggered by upcoming data and executive presence at key industry conferences.

Shareholders are tightly focused on the pending release of 52-week clinical trial results, anticipating a major catalyst for price appreciation.

Retail investors are actively loading up on shares despite market volatility, viewing the current price as a discount before expected news catalysts.

The stock has seen a surge in community attention and social media ranking, fueling optimism ahead of upcoming presentations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.93	--	--	N/A
Q1 '26	-$0.89	-$0.98	-9.89%	MISSED
Q4 '25	-$0.97	--	--	N/A
Q3 '25	-$0.88	-$1.10	-25.17%	MISSED
Q2 '25	-$0.71	-$0.87	-21.82%	MISSED

MLTXMoonLake Immunotherapeutics

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Latest MLTX News